Trial Profile
A Multi-Center Phase III Study to Evaluate Malathion Gel 0.5% Formulation, for the Control of Head Lice in Pediatric Subjects and Adult Subjects With Pediculosis Capitis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 22 Oct 2014
Price :
$35
*
At a glance
- Drugs Malathion (Primary)
- Indications Pediculosis
- Focus Registrational; Therapeutic Use
- Sponsors Taro Pharmaceuticals USA
- 22 Oct 2014 New trial record